Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Canopy Growth Corp T.WEED

Alternate Symbol(s):  CGC | T.WEED.DB

Canopy Growth Corporation is a cannabis and consumer packaged goods (CPG) company. The Company delivers innovative products with a focus on premium and mainstream cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space. Its CPG portfolio includes gourmet wellness products by Martha Stewart CBD, and vaporizer technology made in Germany by Storz & Bickel. The principal activities of the Company are the production, distribution, and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. Its Canada cannabis segment includes the production, distribution, and sale of a diverse range of cannabis, hemp, and cannabis products in Canada. Its Rest-of-world cannabis segment includes the production, distribution, and sale of a diverse range of cannabis and hemp products internationally. Its Storz & Bickel segment includes the production, distribution, and sale of vaporizers.


TSX:WEED - Post by User

Comment by DSEEGSon Aug 07, 2020 12:45am
236 Views
Post# 31377175

RE:Checked Yahoo Finance

RE:Checked Yahoo Finance
stocktradinguru wrote: For earnings estimates---low is $67 and high of $105 million aprox...

I have no clue what the earnings will be, but it seems they will not be close to APHA's $159 million for the quarter.

Now Weed moves in another direction---which likely means they cannot make the desired sales and earning growth on the current blue print.

Earnings announced on August 10th.

There could be a "sh-t strom" if earnings are low---like $69 million for the quarter.

I don't own any Canopy at this time, because in my view, this stock is way overvalued and has too much debt.

Aphria is a better buy!!!

Lets see what happens..

 


Aphria  cannabis revenue was 53.1 m .

Aphria has many positives but they still have alot of work to do. 

APH inventory is balooning . 7 quarters of inventory in their warehouse and no slowdown in production . Half billion writedown is possible if keep production at this rate.

Trim writedown coming as well. . 25 cents for trim. Last quarter was 2.11

They were also in breach of its debt service ratio loan.  Luckily they got a waiver until the end of the year or it could have resulted in a sudden loan call back, this can still happen if they dont meet this covenent .

ATM program they setup can cause dilution for shareholders. 100,000,000 shares.


Hopefully Canopy and Aphria will do well . They need to work through some issues but both have many positives to focus on . Imo Canopy exposure statessideCBD ,Future and existing partnetships puts Canopy Ceiling much higher.


 

<< Previous
Bullboard Posts
Next >>